This study analysed the weekly incidence of T1D in children and adolescents under 20 years of age during the COVID-19 pandemic from March 2020 to December 2021, based on new insulin prescriptions from 2016 to 2021 using the IQVIA longitudinal prescription database (LRx). This evidence concerns the gene INS and type 1 diabetes mellitus.